A new study suggests that a urine-based biomarker test shows promise in forecasting bladder cancer treatment response, which ...
Bladder cancer survivors and a therapist share the realities of living with a stoma and how relatives can support loved ones ...
Pfizer (NYSE:PFE) received U.S. FDA Priority Review for a supplemental Biologics License Application covering PADCEV plus ...
ANKTIVA approved for patients with certain indications of non-muscle invasive bladder cancer and non-small cell lung cancer -- Commercial availability achieved within two months of announcing MENA ...
Zacks Investment Research on MSN
MRK's SBLAs for Keytruda combo in bladder cancer get FDA priority tag
Merck MRK announced that the FDA has accepted the two supplemental biologics license applications (sBLAs) seeking approval ...
A phase 2 study evaluated the efficacy and safety of adding pembrolizumab to trimodal therapy as a bladder-sparing approach for muscle-invasive bladder cancer (MIBC).
Plus, how to tell it apart from more common infections.
At the 2026 NCCN Annual Meeting, Dr. Charles Peyton spoke with CURE about how a growing number of treatment options is ...
Chemotherapy uses medicines to kill fast-growing cells (like cancer cells) or to keep them from dividing (which is how cancers grow). It is a systemic treatment. This means the medicines will travel ...
Colorado football coach Deion Sanders was diagnosed with an aggressive form of bladder cancer earlier this year, had surgery to remove the organ and is now considered cured by his doctors, the Pro ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the U.S. Food and Drug ...
Eugene Lim, who inspired thousands in the running community, was diagnosed with stage 4 bladder cancer in 2024 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results